FDA Device Recalls

Recalls /

#90064

Product

Leksell SurgiPlan

FDA product code
HAWNeurological Stereotaxic Instrument
Device class
Class 2
Medical specialty
Neurology
510(k) numbers
K943468
Affected lot / code info
US68104248, SG50425261, US68154313, US66320311, 3415G15729, 3416G05185, SW ONLY, 3416G07810, 3416G08464, US19311023, SG5121735, SG44720158, 000000000000010, SG33221023, 000000000000015, SG41020267, US19477688, SG14720637, SG31020878, SG21220437, IE24488098, SG11720734, US6836799, SG20220679, US68064889, US19344670, SG41720337, SG44820136, US6863578, US68247174, SG20220701, 000000000000011, 6458A30012, HP715/80, 000000000000019, 3628G06513, SG5020708, SG31120383, LGP-SG13420315, 000000000000014, 00000000000004, 3711C04231, US68154724, C160, SG33820630, 00000000000002, 000000000000013, 6146A06124, SG41920535, 6513A30173, 0304011939, A4986A, SG20220694, 000000000000016, SG20220699, 6601A30228, US19476876

Why it was recalled

Images from a different patient can be imported without a warning for the user.

Root cause (FDA determination)

Other

Action the firm took

Phase I - A technical note for LGP and SPS describing the risk for importing wrong image files and including recommendations on how to reduce this risk has been written and distributed to users of both Leksell GammaPlan and Leksell SurgiPlan on May 23, 2005 via FCO DOC 05-0001. Phase 2 - A maintenance release was created of the Scanner Interface (SIF) to correct the problem. This was distributed to Leksell SurgiPlan users on November 30, 2005 via FCO0000153-1. Additional questions are directed to the firm to Product Manager lrobert.aslund AT elekta.com, or After Sales gustaf.piehl AT elekta.com..

Recalling firm

Firm
Elekta, Inc.
Address
4775 Peachtree Industrial Blvd, Bldg 300 # 300, Norcross, Georgia 30092-3011

Distribution

Distribution pattern
Nationwide, Canada and Mexico.

Timeline

Recall initiated
2005-05-23
Posted by FDA
2010-04-22
Terminated
2010-12-14
Status

Source: openFDA Device Recall endpoint. Recall record ID #90064. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.